Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP17334.RASmVymkn5EqXG2ctiaxNephinWpS6dX8Nprp1IUuU1L4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP17334.RASmVymkn5EqXG2ctiaxNephinWpS6dX8Nprp1IUuU1L4130_assertion type Assertion NP17334.RASmVymkn5EqXG2ctiaxNephinWpS6dX8Nprp1IUuU1L4130_head.
- NP17334.RASmVymkn5EqXG2ctiaxNephinWpS6dX8Nprp1IUuU1L4130_assertion description "[In Experiment 1, the drug scopolamine (1 or 2 mg/kg, ip) was used to induce amnesia prior to training, and GRP (32 nmol/kg, ip) or saline (control) was administered immediately after training.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP17334.RASmVymkn5EqXG2ctiaxNephinWpS6dX8Nprp1IUuU1L4130_provenance.
- NP17334.RASmVymkn5EqXG2ctiaxNephinWpS6dX8Nprp1IUuU1L4130_assertion evidence source_evidence_curated NP17334.RASmVymkn5EqXG2ctiaxNephinWpS6dX8Nprp1IUuU1L4130_provenance.
- NP17334.RASmVymkn5EqXG2ctiaxNephinWpS6dX8Nprp1IUuU1L4130_assertion SIO_000772 11564462 NP17334.RASmVymkn5EqXG2ctiaxNephinWpS6dX8Nprp1IUuU1L4130_provenance.
- NP17334.RASmVymkn5EqXG2ctiaxNephinWpS6dX8Nprp1IUuU1L4130_assertion wasDerivedFrom ctd_human-20130708 NP17334.RASmVymkn5EqXG2ctiaxNephinWpS6dX8Nprp1IUuU1L4130_provenance.
- NP17334.RASmVymkn5EqXG2ctiaxNephinWpS6dX8Nprp1IUuU1L4130_assertion wasGeneratedBy ECO_0000218 NP17334.RASmVymkn5EqXG2ctiaxNephinWpS6dX8Nprp1IUuU1L4130_provenance.